Skip to main content
. 2024 Jan 3;17(1):sfae002. doi: 10.1093/ckj/sfae002

Figure 1:

Figure 1:

Scheme of plasma and urine sampling. (A) Patient with normal GFR with 24-h dosing interval; (B) patient with severely decreased GFR with 48-h dosing interval; (C) patient with moderately reduced GFR with 36-h dosing interval. The urine sampling was irregular due to the clinical issues. AM: infusion of amikacin.